MedTrace Logo

CGM in Utah Valley

NCT04313803 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2020-03-18

No results posted yet for this study

Summary

The purpose of this study is to replicate the positive impact observed in IRB #1050955, but conduct this over a shorter period to potentially maximize patient outcomes and make care more affordable. Intermountain intends to build a diabetes program with CGM based on the findings. Senior stakeholders, clinicians and operators are aligned on this vision including the Community Based Care triad, Executive Leadership Team, and our Diabetes Prevention Program.

Conditions

Interventions

DEVICE

CGM

Dexcom CGM system

Sponsors & Collaborators

  • DexCom, Inc.

    collaborator INDUSTRY

  • Intermountain Health Care, Inc.

    lead OTHER

Principal Investigators

  • Elizabeth Joy, MD, MPH · Intermountain Health Care, Inc.

  • Brad Isaacson, PhD, MBA, MSF, PMP · Intermountain Health Care, Inc.

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-10-30
Completion
2021-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04313803 on ClinicalTrials.gov